New analysis finds escitalopram prevents depression relapse better than other drugs
A large study published in The Lancet Psychiatry found that the antidepressant escitalopram was more effective at preventing relapse than several other common medications.

Study covers nearly 10,000 patients
The analysis examined data from previous studies involving almost 10,000 people prescribed different antidepressants for up to a year. Escitalopram performed best at keeping patients free of depression symptoms while two other pills ranked next in the list. Prozac also known as fluoxetine ranked just below them while agomelatine and duloxetine came second in the ranking order.
Experts warn against switching drugs
Prof Eric Ruhé from Radboud University stated that medication choice can vary for each individual patient based on their specific needs. Dr Sameer Jauhar at Imperial College London added that the research cannot tell which antidepressant will work best for a single person. Prof Allan Young from the Royal College of Psychiatrists noted that modest differences are unlikely to outweigh side effects or patient preference.
Treatment options include therapy and pills
Depression affects around one in six people in the UK according to medical data available to researchers. Doctors already recommend staying on antidepressants for at least six months after symptoms end before tapering off gradually. Patients should discuss treatment options with their doctor because all drugs have pros and cons that must be considered.
Reported by one outlet
Only one outlet has published this. Nothing here has been checked against a second report, so read it as that outlet's account and follow the link below for the original.
Reported by
1 independent outlet. Headline as published. Links open the original report.